INTRODUCTION

Aurora Kinases and the Cell Cycle
The Cell cycle is an ordered set of events, culminating in cell growth and division into two daughter cells. The segregation of genetic material into two exact halves is the hallmark of cell division. The chromosomal DNA is replicated during S phase (DNA synthesis). The G1 phase or fi rst gap phase is the interval between mitosis and DNA replication. The G2 phase or second gap phase is the interval between completion of DNA replication and mitosis. Mitosis is divided into fi ve distinct stages (prophase, prometaphase, metaphase, anaphase and telophase) and the end of mitosis, two daughter cells are formed from one parent cell by cytokinesis. In brief, prophase begins after the transition from G2 to mitosis and chromosome condensation and disassembly of the nuclear envelope are key events. Attachment of chromosome kinetochores to microtubules and the assembly of chromosomes at the center of the cell to form the metaphase plate are the main events in prometaphase and metaphase respectively. Sister chromatids move to opposite pole and the poles move apart during anaphase. During telophase, the chromosomes recondense and the nuclear envelop reforms around genetic material. The most dramatic change in cellular structure at this time is constriction of the cleavage furrow and subsequent cytokinesis (Fig. 1) .
These strict molecular events taking place in strict order during the cell cycle is responsible for reliable cell division to produce two daughter cells as precise copies of the parent cell. Biochemical points termed checkpoints, control transitions in the cell cycle to ensure the fi delity and progression into following stage. Mutations or over expression of the genes involved in these checkpoints can cause cancer. Such genes are called oncogenes. The fi rst checkpoint occurs at the end of G1 phase and before S phase, called G1 checkpoint or restriction checkpoint. The second checkpoint occurring at the end of G2 phase and before mitotic phase is called the G2 checkpoint. Apart from these two checkpoints one more stage called (Fig. 1) . The Aurora kinases are importantly involved in cell cycle and they exhibit most of their known functions in mitosis. They are involved in some checkpoint regulation pathways including spindle assembly checkpoint, alignment of metaphase chromosomes and chromosomal biorientation. Aberrant expression of Aurora kinases may disturb checkpoint functions particularly in mitosis and this may lead to genetic instability and trigger the development of tumors. Aurora kinases have gained much attention since they were identifi ed as bona fi de oncogenes.
Structure
Aurora kinases, divided into A, B, and C have an amino acid sequence length ranging from 309-403 (ref. (15) (16) (17) (18) (19) (20) (Fig. 2) . Aurora A and B share 71% identity in their C-terminal catalytic domain 2 . The high percentage of conservation is very important in relation to the specifi city of substrates and inhibitors. The mean proportion of similar amino acids estimated by pair-wise sequence comparisons is significantly higher among diff erent families of Aurora A, B and C in vertebrates (0.84 ± 0.5) than within the same family (Aurora A or B) in vertebrates and invertebrates species (0.69 ± 0.3 for both). This suggests a recent evolutionary radiation of Aurora families within vertebrates 3 . Structural and motif based comparison suggested an early divergence of Aurora A from Aurora B and Aurora C (ref. 4 ). Aurora A, B, &C have been mapped on chromosomes 20q13.2, 17p13.1, and 10q13 respectively [5] [6] [7] . Aurora kinases show little variability in their amino acid sequence and this is very important for interaction with diff erent substrates specifi c for each Aurora kinase and for their diff erent subcellular localizations 8 . ATP binding active site in all Aurora kinases are lined by 26 residues and three variants: Leu215, Thr217, R220 are specifi c to Aurora A. Aurora A, B, and C share identical sequences in their active site 3 .
Aurora Kinase Geography and Substrates
Aurora kinases are nuclear proteins having diff erent sub cellular locations. Aurora A localizes within the centrosomes from the time of duplication of centromeres until mitotic exit 2 . Bischoff et al. 5 using indirect immunofl uorescence with Aurora A antibodies found the specifi c localization of Aurora A. Aurora A localizes to centrosomes, spindle poles, spindle from prophase to metaphase but predominantly to the spindle during telophase 5 ( Fig. 3 ). Northern blot analysis has confi rmed Aurora A expression in thymus, testis and fetal liver and low expression in bone marrow, lymph node and spleen 5 . Late mitosis or early G1 stage is the degradation point for Aurora A. Aurora B, known as chromosomal passenger protein localizes to kinetochores from prophase to metaphase, in the mid zone during anaphase and eventually to the midbody in cytokinesis 5 ( Fig. 3) . Northern blot has shown that human Aurora B expression level is high in normal thymus and fetal liver 5 . Aurora C localizes to centrosomes from anaphase to cytokinesis 9 . It is predominantly expressed in testis and isolated from cDNA library 7 .
A number of substrates of Aurora kinases have been reported by several studies. Some substrates activate Aurora kinases, while others are activated by Aurora kinases. The best-known substrate of Aurora A is TPX2. During mitosis Aurora A is activated by autophosphorylation through the interaction with TPX2. Hence TPX2 is considered a substrate and activator of Aurora A (ref. 10 ). Other substrates of Aurora A include LIM protein 11 , Eg5 (ref. 12 ), CDC25B (ref. 13 ), p53 (ref. 14 ) , and BRCA-1 (ref. 15 ). Substrates for Aurora B include histone H3 (Ser10) (ref. 16 ), MCAK (ref. 17 ), histone H2A (T119) (ref. 18 ), Topoisomerase II (ref. 19 ), INCENP, survivin 20 , and CENP-A (ref. 21 ). The only best-known substrate for Aurora C is INCENP (ref. 22 ). Identifi cation of further substrates is important to develop biomarkers for assessing the effi cacy of targeted drug cancer treatment. . Defects in chromosome biorientation leads to monotelic (one kinetochore attached to spindle pole), merotelic (one kinetochore attached to both spindle poles), and Syntelic attachments (both kinetochores attached to same spindle pole). Aurora B is involved in correcting merotelic and syntelic attachments. Aberrant expression of Aurora B compromises chromosomal biorientation (amphitelic) leading to genetic instability (aneuploidy).
Aurora Kinases Functions
Aurora kinases are involved in multiple functions of mitosis. Aurora A is involved in mitotic entry, separation of centriole pairs, accurate bipolar spindle assembly, and alignment of metaphase chromosomes and completion of cytokinesis 23 . The activity of Aurora A is closely related to centrosomes. It plays a role in bipolar spindle assembly, maturation of duplicated centrosomes by recruiting proteins including D-Tacc 24 , γ-tubulin 25 , SPD-2 (ref. 26 ), and centromeric ChToh 27 . Recently role of Aurora A in the promotion of nuclear envelop breakdown has been described 28 . Aurora B is one of the main components of the chromosomal passenger complex, which is a functional mitotic structure. It is involved in chromosomal bi-orientation, regulating kinetochores microtubule association and cytokinesis 29 . Incorrect attachments of sister chromatid kinetochores to microtubules can be resolved by Aurora B 17, 30 (Fig. 4) . Inhibition of Aurora B by small molecule inhibitor, Hesperadin, signifi cantly increased syntelic attachment, which may lead to genetic instability 30 (Fig. 4) . Aurora B is specifi cally enriched at merotelic attachment sites and is involved in the release of improper kinetochore microtubule attachments during chromosomal bi-orientation 17 (Fig. 4) . Aurora B phosphorylates histone H3 (Ser 10), which is believed to aid in chromatin condensation and separation 16 . Aurora C exhibits similar functions to those assigned to Aurora B and is required for cytokinesis 22 . Hence Aurora C may be as important a kinase as other kinases in the regulation of various mitotic events.
Recently, the involvement of Aurora B in phosphorylation of centromere-specifi c histone 2A at T119, which may be crucial for regulation of chromatin structure and function, has been described 18 . Li et al. 22 found that direct association with INCENP activates Aurora C, suggesting the cooperation of Aurora A and B in the regulation of mitotic events. This led to the question, whether Aurora C can fulfi ll the fucntions of Aurora B. Indeed, recent publications show that Aurora C can complement the functions of Aurora B. It co-localizes with Aurora B and survivin as a chromosomal passenger protein and is able to rescue polyploidy induced by inactive Aurora B. In summary Aurora C appears to exhibit functions similar to those for Aurora B and is required for cytokinesis 22 .
Regulation of Aurora Kinases
Phosphorylation, dephosphorylation are the two predominant mechanisms regulating Aurora A activity most of which have been deduced from invertebrates. Generally, phosphorylation of Aurora kinase stimulates kinase activity and three phosphorylation sites in Xenopus have been identifi ed by mass spectrometry. Littlepage 31 . Mutation in Ser-53 abolished Cdh1 mediated degradation, showing that phosphorylation is invovled in the regualtion of degradation. PP1 phosphatase negatively regulates Aurora A by dephosphorylating T288 (ref. 32 ). In mitotsis Aurora A is activated by autophosphorylation through the interaction with TPX2 and could be at least partly due to PP1 antogonism 10 . Kei Honda et al. 33 demonstrated that Aurora A is turned over by APC-ubiquitin-proteasome pathway. Aurora A degradation is mediated by Cdh1 or Fizzy related once the D-box is recognized 34 . It has also been shown that Chk1 can phosphorylate Aurora B In vitro, enhancing the kinase activity to augment spindle checkpoint signalling 35 . To date the best known regulators of Aurora B include Survivin and INCENP. Survivin binds to the catalytic domain of Aurora B and enhances the kinase activity and targeting to its substrates 36 . Lower levels of phosphorylated Histone H3 correlates with the absence of Survivin, confi rming that Aurora B activity is enhanced by survivin 36 . Survivin is also involved in the localization of Aurora B to diff erent locations during mitotsis. Kie Honda et al. described activation of Aurora B by C-terminal region of INCENP (ref. 37 ). Aurora B is activated upon binding of INCENP resulting in the phosphorylation of the conserved motif of INCENP. These events are critical for full activation of Aurora B/INCENP complex 37 . CENP-A is also invlolved in the regualtion of Aurora B localization to centromeres and spindle midzone 21 . Cdh1 and cdc20 are involved in Aurora B degradation and require intact KEN boxes and A-boxes, which are located within the fi rst 65 amino acids 38 . Levels of Aurora C peak later stages of mitosis after Aurora B. Aurora C is regulated by INCENP like Aurora B, through the C-terminal region. Aurora C may rescue the genetic stability of the cells complementing Aurora B functions in its absence 39 . However regulation of Aurora C is not completely known and further work is needed. Aurora C is predicted to turn over by APC-ubiquitin-proteasome pathway through the recognition of D-box.
Aurora Kinases and Cancer
Aurora kinases perform important functions during mitosis and hence their aberrant expression can lead to the cell transformations underlying cancer. In many tissues, Aurora kinase over-expression leads to genetic instability (aneuploidy), which may cause cancer. Aneuploidy, a condition where the cells have altered, DNA content may arise from mitotic defects including centrosome duplication, centrosome separation, cytokinesis and chromosomal bi-orientation errors. In all these processes Aurora kinases are involved. Therefore it is tempting to state that the aberrant expression of Aurora kinases may lead to aneuploidy. Hence Aurora genes have been classifi ed as bona fi de oncogenes.
Aurora A gene was first named as BTAK (Breast Tumor Activated Kinase), because its mRNA is found to over-expressed in breast tumors and plays a critical role in breast tumor cells transformation 40 . In fact the 5 , which can induce tumors in nude mice. These reports are a break-through and the Aurora kinases came into light attracting more attention than ever before. Zhou et al. 41 performed northern-blot and southern-blot and reported 2.5-8 fold amplifi cation of Aurora A in many cell tumors including breast (BT474, MDA-MB-231), ovarian (2774, SK-OV3), colon (HCT116, HT29, SW480), prostate (DU145, PC3), leukemia (HL60, K562), neural (HTB10) and cervical (SW756). Functional polymorphism due to transitions resulting Phe31Ile has been observed and polymorphism is associated strongly with human colon tumors 42 . Recently similar polymorphisms have been reported in lung cancer predominant in Caucasians 43 . Apart from these tumor types, Aurora A over-expression has been reported in many other tumors (Table 1) . Taken together these data, suggest that Aurora A can be characterized as a bona fi de oncogene.
Aberrant expression of Aurora B also induces tumor formation and this is not surprising as the kinase is involved in many functions during mitosis. Hence it is logical to classify Aurora B as an oncogene. Katayama et al. performed in situ hybridization, northern and western blot studies from surgically resected colon tumor specimens and reported the over-expression of Aurora B and tumor progression 44 . This signifi cant research stimulated interest in the development of new drugs against Aurora B. Malignant progression of thyroid anaplastic carcinoma cells correlates with the over-expression of Aurora B 45 . Over-expression of Aurora B has also been reported in oral cancer 46 and primary non-small cell lung carcinoma 47 . Aurora B has found to be over-expressed in some other tumor types (Table 1) . Aurora C has been found to be over-expressed in some cancer cell lines including HepG2, HUH7, MDA-MB-453 and HeLa. However its correlation with cancer progression is unclear 9 . Hence active research is underway to determine Aurora C as an oncogene.
Based on these reports it is reasonable to classify Aurora kinases as oncogenes. They are not aberrantly expressed in one particular type of tumors only, unlike some other oncogenic kinases. Hence developing potential Aurora kinase inhibitors can target wide range of tumor types. Development of drugs that focus on the Aurora kinases could be promising in the treatment of various cancers. Some Aurora kinases inhibitors have been developed recently and indeed some drugs are in preclinical stage and phase 1 and phase 11 clinical trials. Further research on Aurora kinases is required to determine their regulation and their interaction with other partners.
CONCLUSION
Chromosomal duplication and cell division are very critical, where one copy of each duplicated chromosome segregates to each of two daughter cells. In order to ensure the fi delity of the cell cycle, various proteins regulate the orderly events at each stage of the cell cycle checkpoints. Mutations or aberrant expression of these proteins involved in the cell cycle regulation may lead to tumorigenesis. The importance of evolutionary conserved Aurora kinases in the regulation of mitotic events came into light recently. They are involved in the regulation of microtubule dynamics, chromosomal segregation, and cytokinesis. These kinases are frequently over-expressed in human tumors resulting in genomic instability. Hence they are clearly implicated in tumorigenesis. Recently Aurora kinases are considered as interesting targets for the development of anticancer drugs. Some Aurora kinases developed recently have proven eff ective in the clinic on a wide range of tumors. Further understanding the regulation and functions of Aurora kinases deeply, may help to develop potentially useful drugs for targeted cancer treatment.
